Sarcoidosis is a systemic disease of unknown etiology. It is characterized by the presence of non-necrotizing granulomas distributed along the lymphatics in the peribronchovascular (axial ...

The increase in the global burden of interstitial lung disease (ILD) and pulmonary sarcoidosis had the greatest impact on ...

Sarcoidosis is a rare systemic disease that afflicts an estimated 200,000 people in the US, more often people who are Black and more women than men, particularly when it causes chronic skin disease.

Sarcoidosis is a rare inflammatory condition that develops when groups of cells in your immune system form patches of swollen ...

Sarcoidosis is a systemic inflammatory disorder of unknown etiology, characterized by the formation of noncaseating granulomas, multisystem involvement, intrathoracic (pulmonary and lymph node ...

This condition is known as cardiac sarcoidosis (CS). Myocarditis is a disease condition causing inflammation in the heart muscles. It can progress into a chronic form known as inflammatory ...

The University of Alabama at Birmingham’s Multidisciplinary Sarcoidosis Clinic has joined the Foundation for Sarcoidosis Research (FSR) as a founding member in their Global Sarcoidosis Alliance (GSA).

Considering taking supplements to treat sarcoidosis? Below is a list of common natural remedies used to treat or reduce the symptoms of sarcoidosis. Follow the links to read common uses ...

Additionally, the Phase 3 trial of efzofitimod for pulmonary sarcoidosis is seen as a pivotal opportunity for aTyr Pharma, given the high unmet medical need in this area. With no FDA-approved ...